WaVe Life Sciences Ltd

WVE64

$15.89arrow_drop_down3.34%-$0.55

WVE64

$15.89

arrow_drop_down3.34%-$0.55

Performance History

Key Stats
Open	$16.30
Prev. Close	$16.44
EPS	-0.57
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	15.92	17.06
52 Week Range	3.50	17.06

Ratios







EPS	-0.57

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About WaVe Life Sciences Ltd (WVE)

WaVe Life Sciences Ltd (WVE) is a biotechnology company that focuses on developing nucleic acid-based therapies for the treatment of rare genetic diseases. The company's lead product candidate, WVE-120102, is being developed for the treatment of Huntington's disease. Huntington's disease is a neurodegenerative disorder caused by a mutation in the huntingtin gene. There are currently no approved treatments for this devastating disease, and WVE-120102 has the potential to be a game-changer in the field of neurology.

WVE has a strong pipeline of product candidates in various stages of development. The company's platform technology enables the development of highly specific, RNA-targeted therapies that can address the underlying cause of genetic diseases. In addition to Huntington's disease, WVE is also developing therapies for other neurological disorders, such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Paul B. Bolno M.B.A., M.D., MBA
Headquarters: Singapore
Employees: 250
Exchange: NASDAQ

Keep an eye on WaVe Life Sciences Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is WaVe Life Sciences Ltd's (WVE) price per share?

The current price per share for WaVe Life Sciences Ltd (WVE) is $15.89. The stock has seen a price change of -$0.55 recently, indicating a -3.35% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for WaVe Life Sciences Ltd (WVE)?

For WaVe Life Sciences Ltd (WVE), the 52-week high is $17.06, which is 7.36% from the current price. The 52-week low is $3.5, the current price is 354% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is WaVe Life Sciences Ltd (WVE) a growth stock?

WaVe Life Sciences Ltd (WVE) has shown an average price growth of -3.67% over the past three years. It has received a score of 91 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying WaVe Life Sciences Ltd as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is WaVe Life Sciences Ltd (WVE) stock price performance year to date (YTD)?

As of the latest data, WaVe Life Sciences Ltd (WVE) has a year-to-date price change of 197.57%. Over the past month, the stock has experienced a price change of 82.02%. Over the last three months, the change has been 195.9%. Over the past six months, the figure is 179.26%. Looking at a longer horizon, the five-year price change stands at -43.77%.

help

Is WaVe Life Sciences Ltd (WVE) a profitable company?

WaVe Life Sciences Ltd (WVE) has a net income of -$57.51M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 91.88% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -177.72% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $113.3M, although specific revenue growth data is currently not available. The gross profit is $104.1M. Operating income is noted at -$68M. Furthermore, the EBITDA is -$79.37M.

help

What is the market capitalization of WaVe Life Sciences Ltd (WVE)?

WaVe Life Sciences Ltd (WVE) has a market capitalization of $2.42B. The average daily trading volume is 15.94, indicating the stock's liquidity and investor engagement.